Sulfonylureas Market is Valued at USD 8,485.43 Million at a Potential Growth Rate During the Forecast Period 2029
Sulfonylureas Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.
In recent years, the sulfonylureas market is anticipated to grow rapidly during the forecast period. As per the World Health Organization, approximately 1.9 billion adults were overweight in 2016, with around 650 million being obese. Diabetes is becoming more common due to risk factors such as obesity and overweight. As a result, risk factors including smoking, being overweight, being obese, and having high cholesterol levels are projected to increase the prevalence of diabetes, increasing the demand for sulfonylureas market. Sulfonylureas are oral hypoglycaemic medication used to treat type 2 diabetes. The sulfonylureas cause the pancreas to secrete more insulin.
Data Bridge Market Research analyses that the sulfonylureas market was valued at USD 6,600.44 million in 2021 and is expected to reach USD 8,485.43 million by 2029, registering a CAGR of 3.19% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Sulfonylureas are a class of drugs that are used to treat type 2 diabetes. Sulfonylureas function by decreasing blood glucose levels and increasing the secretion of insulin from the pancreas’ beta cells. Sulfonylureas do not operate in patients with type 1 diabetes because their effect is dependent on the presence of active beta cells. Sulfonylureas promote insulin release by inhibiting ATP-sensitive potassium channels by lowering potassium permeability in beta cells. This causes the cell to depolarize and enhance calcium entry, resulting in an increase in insulin secretion.
Download the Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sulfonylureas-market
Sulfonylureas Market Dynamics
Drivers
Rise in the prevalence of type 2 diabetes across the globe
The rising prevalence of type 2 diabetes across the globe is a major factor driving the sulfonylureas market’s growth rate. Sulfonylureas are usually the second line of treatment for type 2 diabetes patients. In recent years, the global diabetic population has exploded, with type 2 diabetes accounting for about 90% of all diabetics.
Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of sulfonylureas market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Growing number of geriatric population
The rising geriatric population is expected to enhance the growth rate of sulfonylureas market. Sulfonylureas are generally used as a last alternative for people with type 2 diabetes. The global diabetic population has grown in recent years, with type 2 diabetes accounting for about 90% of all diabetics. As people get older, the prevalence of type 2 diabetes rises, as does the risk of coronary heart disease, vascular illness, and stroke. Patients with diabetes who are older are at a higher risk of sarcopenia and physical impairment.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the sulfonylureas market. Additionally, changing lifestyle of people and increasing incidences of obesity will result in the expansion of sulfonylureas market.
Opportunities
Increase in the number of research and development activities
Moreover, the market’s growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the sulfonylureas market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate. The advent of new and more efficient diabetic treatment and monitoring products is estimated to boost the market’s growth rate in the future.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the sulfonylureas market growth during the forecast period.
Global Sulfonylureas Market Scope
The sulfonylureas market is segmented on the basis of drugs, indication, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
Glyburide
Glipizide
Glimepiride
Others
Indication
Diabetes
Others
Dosage form
Tablets
Others
Route of Administration
Oral
Others
End-Users
Specialty Clinics
Homecare
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
To Get a Detailed Table of Contents (TOC), please Click Here at @ https://www.databridgemarketresearch.com/toc/?dbmr=global-sulfonylureas-market
Sulfonylureas Market Regional Analysis/Insights
The sulfonylureas market is analysed and market size insights and trends are provided by country, drugs, indication, dosage form, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Sulfonylureas market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the sulfonylureas market because of the growing presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, increasing prevalence of diabetes will further influence the market’s growth rate in this region
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to surging number of population and growing awareness about diabetes in this region. Also, development of healthcare infrastructure and increasing government initiatives will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Sulfonylureas Market Share Analysis
The Sulfonylureas market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to sulfonylureas market.
Some of the major players operating in the sulfonylureas market are:
Amneal Pharmaceuticals LLC. (US)
Dr. Reddy’s Laboratories Ltd. (India)
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
Bausch Health Companies Inc. (Canada)
Eli Lilly and Company (US)
AbbVie Inc. (US)
Abbott (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Novartis AG (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Allergan (Ireland)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Zydus Cadila (India)
Hikma Pharmaceuticals PLC (UK)
Cipla Inc. (US)
Apotex Inc. (Canada)
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-sulfonylureas-market
Research Methodology:
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Top Trendings Reports:-
https://www.databridgemarketresearch.com/reports/global-vendor-neutral-archive-vna-market
https://www.databridgemarketresearch.com/reports/global-anesthesia-monitoring-devices-market
https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market
https://www.databridgemarketresearch.com/reports/global-cell-permeabilization-market
https://www.databridgemarketresearch.com/reports/global-tangential-flow-filtration-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
